Development of intravenous lipid emulsion of α-asarone with significantly improved safety and enhanced efficacy

Abstract Severe adverse events have been frequently associated with taking the commercially available formulation of α-asarone injection (α-asarone-I). Hence, we sought to develop an intravenous lipid emulsion of α-asarone (α-asarone-LE), where we hypothesized that these adverse events could be prev...
Ausführliche Beschreibung

Gespeichert in:
Autor*in:

Ma, Wei-Cong [verfasserIn]

Zhang, Qing

Li, Hui

Larregieu, Caroline A.

Zhang, Na

Chu, Ting

Jin, Hui

Mao, Sheng-Jun

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2013transfer abstract

Schlagwörter:

Lipid emulsion

Formulation optimization

Asthma treatment

α-Asarone

Safety evaluation

Umfang:

10

Übergeordnetes Werk:

Enthalten in: Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides - Nigolian, H. ELSEVIER, 2022, New York, NY [u.a.]

Übergeordnetes Werk:

volume:450 ; year:2013 ; number:1 ; day:25 ; month:06 ; pages:21-30 ; extent:10

Links:

Volltext

DOI / URN:

10.1016/j.ijpharm.2013.04.023

Katalog-ID:

ELV021958939

Nicht das Richtige dabei?

Schreiben Sie uns!